Search research articles
Contact Us
Filters
Showing results (91-100 of 126) with videos related to
Page
of 13
Sort By:
British Journal of Cancer
|
October 16, 2018
Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy
Jean-David Fumet, Corentin Richard, Fanny Ledys, et al.
British Journal of Cancer
|
June 26, 2019
Correction: Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy
Jean-David Fumet, Corentin Richard, Fanny Ledys, et al.
Nature Communications
|
February 23, 2024
Influence of microbiota-associated metabolic reprogramming on clinical outcome in patients with melanoma from the randomized adjuvant dendritic cell-based MIND-DC trial
Carolina Alves Costa Silva, Gianmarco Piccinno, Déborah Suissa, et al.
Oncoimmunology
|
December 8, 2018
TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer
Alexandre Ivagnès, Meriem Messaoudene, Gautier Stoll, et al.
Oncoimmunology
|
July 14, 2022
<i>Helicobacter pylori</i> serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors
Marion Tonneau, Alexis Nolin-Lapalme, Suzanne Kazandjian, et al.
Cancer Cell
|
January 20, 2022
MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells
Emeric Limagne, Lisa Nuttin, Marion Thibaudin, et al.
The Annals of Thoracic Surgery
|
October 30, 2025
Neoadjuvant Chemotherapy-Immunotherapy in Non-Small Cell Lung Cancer: Can Positron Emission Tomography Scan Predict Complete Pathologic Response?
Joseph Seitlinger, Olivier Salko, Luciano Bulgarelli Maqueda, et al.
Cell Death and Differentiation
|
December 2, 2020
Ileal immune tonus is a prognosis marker of proximal colon cancer in mice and patients
Marion Picard, Satoru Yonekura, Karolina Slowicka, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 22, 2023
Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer
Edouard Auclin, Jose Benitez-Montanez, Marco Tagliamento, et al.
Cell Death and Differentiation
|
May 8, 2021
Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment
Safae Terrisse, Lisa Derosa, Valerio Iebba, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 126) with videos related to
Sort By:
Page
of 13
British Journal of Cancer
|
October 16, 2018
Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy
Jean-David Fumet, Corentin Richard, Fanny Ledys, et al.
British Journal of Cancer
|
June 26, 2019
Correction: Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy
Jean-David Fumet, Corentin Richard, Fanny Ledys, et al.
Nature Communications
|
February 23, 2024
Influence of microbiota-associated metabolic reprogramming on clinical outcome in patients with melanoma from the randomized adjuvant dendritic cell-based MIND-DC trial
Carolina Alves Costa Silva, Gianmarco Piccinno, Déborah Suissa, et al.
Oncoimmunology
|
December 8, 2018
TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer
Alexandre Ivagnès, Meriem Messaoudene, Gautier Stoll, et al.
Oncoimmunology
|
July 14, 2022
<i>Helicobacter pylori</i> serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors
Marion Tonneau, Alexis Nolin-Lapalme, Suzanne Kazandjian, et al.
Cancer Cell
|
January 20, 2022
MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells
Emeric Limagne, Lisa Nuttin, Marion Thibaudin, et al.
The Annals of Thoracic Surgery
|
October 30, 2025
Neoadjuvant Chemotherapy-Immunotherapy in Non-Small Cell Lung Cancer: Can Positron Emission Tomography Scan Predict Complete Pathologic Response?
Joseph Seitlinger, Olivier Salko, Luciano Bulgarelli Maqueda, et al.
Cell Death and Differentiation
|
December 2, 2020
Ileal immune tonus is a prognosis marker of proximal colon cancer in mice and patients
Marion Picard, Satoru Yonekura, Karolina Slowicka, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 22, 2023
Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer
Edouard Auclin, Jose Benitez-Montanez, Marco Tagliamento, et al.
Cell Death and Differentiation
|
May 8, 2021
Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment
Safae Terrisse, Lisa Derosa, Valerio Iebba, et al.
Page
of 13